Browsing by Author "Nomathemba Chandiwana"
Now showing 1 - 17 of 17
- Results Per Page
- Sort Options
Item Determinants of early change in serum creatinine after initiation of dolutegravirbased antiretroviral therapy in South Africa(WILEY-BLACKWELL) R Mpofu; A Kawuma; R Wasmann; Godspower Akpomiemie; Nomathemba Chandiwana; Simiso Sokhela; Willem Venter; Michelle Moorhouse; P Denti; E et alItem Effect of obesity on dolutegravir exposure in Black Southern African adults living with HIVE Mondleki; C Banda; Nomathemba Chandiwana; Simiso Sokhela; L Wiesner; Willem Venter; G Maartens; P SinxadiItem Final 192Week Efficacy and Safety Results of the ADVANCED Trial Comparing 3 Firstline Antiretroviral RegimensSimiso Sokhela; Willem Venter; B Bosch; J Woods; Godspower Akpomiemie; Nomathemba Chandiwana; Angela Tembo; Lucas Hermans; Shane Norris; Lee Fairlie; E et alItem Fine 192week efficacy and safety results of the ADVANCE trial comparing 3 firstline Antiretroviral RegimesSimiso Sokhela; Willem Venter; B Bosch; J Woods; K McCann; Godspower Akpomiemie; Nomathemba Chandiwana; Nonkululeko Mashabane; Angela Tembo; Samanta Lalla-Edward; Lucas Hermans; Lee Fairlie; A Vos; Shane Norris; N Arupallan; et al et alItem Impact of longacting therapies on the global HIV epidemicNomathemba Chandiwana; Celicia M Serenata; Andrew Owen; Steve Rannard; Carmen Perez Casas; A Et AlItem Perceptions of Health Body Size and Nutritional Risk Factors for Obersity in people with HIV in South Africa(SPRINGER/PLENUM PUBLISHERS) Jennifer Manne-Goehler; N Rahim; E van Empel; R De Vlieg; Grace Chamberlin; Nomathemba Chandiwana; et.al et.alItem Pharmacogenetics of Dolutegravir Plasma Exposure Among Southern Africans With Human Immunodeficiency Virus(OXFORD UNIV PRESS INC) Z Cindi; A Kawuma; G Maartens; Y Bradford; Willem Venter; Simiso Sokhela; Nomathemba Chandiwana; E et alItem Pharmacogenetics of tenofovir clearance among Southern Africans living with HIV(LIPPINCOTT WILLIAMS & WILKINS) Z Cindi; A N Kawuma; G Maartens; Y Bradford; Simiso Sokhela; Nomathemba Chandiwana; Willem Venter; E et alItem Regional variation in weight change after the transition to dolutegravir in Uganda and South Africa(LIPPINCOTT WILLIAMS & WILKINS) R Migisha; G Chen; W Muyindike; Taing Aung; Nomathemba Chandiwana; Willem Venter; E et alItem Safety and efficacy of four drug regimens versus standardof care for the treatment of symptomatic outpatients with COVID19 A randomised openlabel multiarm phase 2 clinical trialNomathemba Chandiwana; C Kruger; H Johnstone; M Chughlay; C Ju; Yengiwe Dineka; E et al; Willem VenterItem Safety and efficacy of four drug regimens versus standardof care for the treatment of symptomatic outpatients with COVID19 A randomised openlabel multiarm phase 2 clinical trialNomathemba Chandiwana; C Kruger; H Johnstone; M Chughlay; C Ju; Yengiwe Dineka; E et al; Willem VenterItem Safety and efficacy of four drug regimens versus standardof care for the treatment of symptomatic outpatients with COVID19 A randomised openlabel multiarm phase 2 clinical trialNomathemba Chandiwana; C Kruger; H Johnstone; M Chughlay; C Ju; Yengiwe Dineka; E et al; Willem VenterItem Southern African HIV Clinicians Society Guideline for the clinical management of syphilisR Peters; Jeremy Nel; Mohammad Sadiq; Tendesayi Kufa; D.P Smit; Gillian Sorour; N Garrett; K Gill; L Makhakhe; Nomathemba Chandiwana; E et alItem The predicted risk of adverse pregnancy outcomes as a result of treatmentassociated obesity in a hypothetical population receiving tenofovir alafenamideemtricitabinedolutegravir tenofovir disoproxil fumarateemtricitabinedolutegravir or tenofovir disoSumbul Asif; Evangelia Baxevanidi; Andrew Hill; Willem Venter; Lee Fairlie; Masebole Masenya; Celicia Serenata; Simiso Sokhela; Nomathemba ChandiwanaItem Trends in body mass index for people with and without HIV Pooled analysis of nationallyrepresentative health surveys from 10 countries and 173800 adults in AfricaR Carrillo-Larco; C Bulstra; J Manne-Goehler; M Siedner; E et al; Willem Venter; Samanta Lalla-Edward; Nomathemba ChandiwanaItem Weight and metabolic changes after switching from tenofovir alafenamide/emtricitabine (FTC)+dolutegravir (DTG), tenofovir disoproxil fumarate (TDF)/FTC+DTG and TDF/FTC/efavirenz (EFV) to TDF/lamivudine /DTG(OXFORD UNIV PRESS INC) B Bosch; Godspower Akpomiemie; Nomathemba Chandiwana; Simiso Sokhela; A Hill; K McCann; A Qavi; E et al; Willem VenterItem Weight Gain After HIV Therapy Initiation Pathophysiology and ImplicationsNomathemba Chandiwana; M J Siedner; V C Marconi; A Hill; M K Ali; R L Batterham; Willem Venter